A week after OpenAI made headlines with an A.I.-generated proof, a new “declaration” by 16 experts raises concerns that the ...

A battle between “slimes” and “zoglins” could be the best way to calculate pi—at least for fans of this megahit game ...

If you haven't seen the latest Java developer productivity report from Perforce, you should check it out. Written by Perforce CTO Rod Cope and developer tools exec Jeff Michael, the "2025 Java ...

GREENSBORO, N.C. — Taxes are all about numbers, and each year, millions of math errors are caught by the IRS. For this tax season, taxpayers will now receive letters from the IRS detailing where they ...

Readers express concerns over local issues including roundabout safety, noise ordinances, and political civility. Several letters critique the actions and rhetoric of political figures and their ...

To the editor: In an opinion published Monday, April 27 and titled: “America is losing its most valuable resource: People,” columnist George Will quotes another expert conservative thinker for a ...

To the editor: RFK Jr. said this: “A Democratic senator claimed it’s mathematically impossible to have a drug drop by 600%. I said, ‘Well, if the drug was $100 and it raises to $600, that would be a ...

A friend texted me last week, “Zak, they’re building another car wash in town—what gives?” It’s a fair question. There are already more than a dozen car washes in Flagstaff. How can yet another be an ...

In the United States, facilities that manufacture drugs must implement quality systems that comply with current good manufacturing practice (cGMP) regulations in 21 CFR Parts 210 and 211. While cGMP ...

Before throwing a résumé draft into ChatGPT or asking another AI tool to craft a message to hiring managers, job seekers should avoid a few things. "I never used the wording ChatGPT spit out, but I ...

A woke Canadian academic whose research includes working with young children to create “queer- and trans-centered spaces” is drawing mockery online for his choice of pronouns — his full name, all ...

In the latest tranche of published warning letters, the US Food and Drug Administration (FDA) has continued to go after drugmakers for marketing glucagon-like peptide-1 (GLP-1) receptor agonists and ...